| Literature DB >> 29441702 |
Jianyu Li1,2,3, Eckhard Weber4, Sabine Guth-Gundel4, Michael Schuleit4, Andreas Kuttler4, Christine Halleux4, Nathalie Accart4, Arno Doelemeyer4, Anne Basler4, Bruno Tigani4, Kuno Wuersch4, Mara Fornaro4, Michaela Kneissel4, Alexander Stafford1,2, Benjamin R Freedman1,2, David J Mooney1,2.
Abstract
Hydrogels are under active development for controlled drug delivery, but their clinical translation is limited by low drug loading capacity, deficiencies in mechanical toughness and storage stability, and poor control over the drug release that often results in burst release and short release duration. This work reports a design of composite clay hydrogels, which simultaneously achieve a spectrum of mechanical, storage, and drug loading/releasing properties to address the critical needs from translational perspectives. The clay nanoparticles provide large surface areas to adsorb biological drugs, and assemble into microparticles that are physically trapped within and toughen hydrogel networks. The composite hydrogels demonstrate feasibility of storage, and extended release of large quantities of an insulin-like growth factor-1 mimetic protein (8 mg mL-1 ) over four weeks. The release rate is primarily governed by ionic exchange and can be upregulated by low pH, which is typical for injured tissues. A rodent model of Achilles tendon injury is used to demonstrate that the composite hydrogels allow for highly extended and localized release of biological drugs in vivo, while demonstrating biodegradation and biocompatibility. These attributes make the composite hydrogel a promising system for drug delivery and regenerative medicine.Entities:
Keywords: biological drugs; composite hydrogels; controlled delivery; regenerative medicine; tough hydrogels
Mesh:
Substances:
Year: 2018 PMID: 29441702 PMCID: PMC6192424 DOI: 10.1002/adhm.201701393
Source DB: PubMed Journal: Adv Healthc Mater ISSN: 2192-2640 Impact factor: 9.933